Safety of zonisamide therapy: prospective follow-up survey

Abstract

Zonisamide safety was evaluated based on a postmarketing surveillance study of patients treated for 1-3 years. Nine hundred twenty-eight children and 584 adults (ages 1 month to 79 years), including 372 newly-diagnosed patients, received zonisamide for partial and generalized epilepsies. Of the intractable patients, 1008 received zonisamide in combination… (More)
DOI: 10.1016/j.seizure.2004.04.006

Topics

3 Figures and Tables